CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	May 28, 2026	May 29, 2025	May 28, 2026	May 29, 2025
Income Statement [Abstract]
Revenue	$ 41,456	$ 9,301	$ 78,959	$ 26,063
Cost of goods sold	6,400	5,793	18,502	16,244
Gross margin	35,056	3,508	60,457	9,819
Research and development	1,316	965	3,737	2,751
Selling, general, and administrative	407	318	1,088	891
Other operating (income) expense, net	15	56	43	61
Operating income	33,318	2,169	55,589	6,116
Interest income	215	135	509	350
Interest expense	0	(123)	(106)	(353)
Other non-operating income (expense), net	(321)	(68)	(559)	(90)
Income (loss) before income taxes and equity in net income (loss) of equity method investees	33,212	2,113	55,433	6,023
Income tax (provision) benefit	(4,978)	(235)	(8,178)	(695)
Equity in net income (loss) of equity method investees	9	7	13	10
Net income	$ 28,243	$ 1,885	$ 47,268	$ 5,338
Earnings per share
Basic (in dollars per share)	$ 25.03	$ 1.69	$ 41.97	$ 4.79
Diluted (in dollars per share)	$ 24.67	$ 1.68	$ 41.40	$ 4.75
Number of shares used in per share calculations
Basic (in shares)	1,128	1,118	1,126	1,114
Diluted (in shares)	1,145	1,125	1,142	1,123

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	May 28, 2026	May 29, 2025
Cash flows from operating activities
Net income	$ 47,268	$ 5,338
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	6,862	6,203
Stock-based compensation	954	722
Change in operating assets and liabilities:
Receivables	(19,953)	(123)
Inventories	(212)	148
Accounts payable and accrued expenses	3,329	38
Other current liabilities	2,139	(681)
Other noncurrent liabilities	5,203	259
Other	112	(109)
Net cash provided by operating activities	45,702	11,795
Cash flows from investing activities
Expenditures for property, plant, and equipment	(19,602)	(10,199)
Purchases of available-for-sale securities	(4,072)	(1,203)
Proceeds from government incentives	2,989	1,294
Proceeds from maturities and sales of available-for-sale securities	1,233	1,249
Other	(236)	(30)
Net cash used for investing activities	(19,688)	(8,889)
Cash flows from financing activities
Repayments of debt	(9,380)	(3,604)
Repurchases of common stock - withholdings on employee equity awards	(762)	(290)
Repurchases of common stock - repurchase program	(650)	0
Payments of dividends to shareholders	(437)	(392)
Proceeds from issuance of debt	0	4,430
Other	583	70
Net cash provided by (used for) financing activities	(10,646)	214
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	8	(3)
Net increase in cash, cash equivalents, and restricted cash	15,376	3,117
Cash, cash equivalents, and restricted cash at beginning of period	9,646	7,052
Cash, cash equivalents, and restricted cash at end of period	25,022	10,169
Supplemental disclosure
Non-cash acquisitions of finance lease right-of-use assets	$ 32	$ 1,247

CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions

May 28, 2026

Aug. 28, 2025

Assets

Cash and cash equivalents

$ 24,995

$ 9,642

Short-term investments

1,027

665

Receivables

31,025

9,265

Inventories

8,567

8,355

Other current assets

1,123

914

Total current assets

66,737

28,841

Long-term marketable investments

^[1]

4,106

1,629

Property, plant, and equipment

56,426

46,590

Operating lease right-of-use assets

683

736

Intangible assets

473

453

Deferred tax assets

700

616

Goodwill

1,150

Other noncurrent assets

3,837

2,783

Total assets

134,112

82,798

Liabilities and equity

Accounts payable and accrued expenses

15,521

9,649

Current debt

582

560

Other current liabilities

3,385

1,245

Total current liabilities

19,488

11,454

Long-term debt

5,140

14,017

Noncurrent operating lease liabilities

654

701

Noncurrent unearned government incentives

1,020

1,018

Other noncurrent liabilities

7,086

1,443

Total liabilities

33,388

28,633

Commitments and contingencies

Shareholders’ equity

Common stock, $0.10 par value, 3,000 shares authorized, 1,275 shares issued and 1,129 outstanding (1,266 shares issued and 1,122 outstanding as of August 28, 2025)

128

127

Additional capital

14,442

13,339

Retained earnings

94,682

48,583

Treasury stock, 146 shares held (144 shares as of August 28, 2025)

(8,502)

(7,852)

Accumulated other comprehensive income (loss)

(26)

(32)

Total equity

100,724

54,165

Total liabilities and equity

$ 134,112

$ 82,798

[1]	The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date.